Difference between revisions of "Part:BBa K4156086"
Line 3: | Line 3: | ||
<partinfo>BBa_K4156086 short</partinfo> | <partinfo>BBa_K4156086 short</partinfo> | ||
− | + | CCL21 is an anti-tumor protein. | |
+ | |||
+ | <!-- Add more about the biology of this part here --> | ||
− | |||
===Usage and Biology=== | ===Usage and Biology=== | ||
− | + | It activates host immune response through recruitment of T cells and dendritic cells.CCL21 is used as a therapeutic component to confer therapeutic capability to engineered strains against CRC tumor cells. | |
+ | |||
<span class='h3bb'>Sequence and Features</span> | <span class='h3bb'>Sequence and Features</span> | ||
<partinfo>BBa_K4156086 SequenceAndFeatures</partinfo> | <partinfo>BBa_K4156086 SequenceAndFeatures</partinfo> |
Revision as of 08:37, 9 October 2022
CCL21
CCL21 is an anti-tumor protein.
Usage and Biology
It activates host immune response through recruitment of T cells and dendritic cells.CCL21 is used as a therapeutic component to confer therapeutic capability to engineered strains against CRC tumor cells.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]